Area of research
Economics and Econometrics · History
Research interest
Research interests include Cancer research, Fibroblast growth factor receptor, Pancreatic cancer, Angiogenesis, Fibroblast growth factor, and Cancer cell.
Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.
PubMed 2015cited by 19position: middle
STAT5b as Molecular Target in Pancreatic Cancer—Inhibition of Tumor Growth, Angiogenesis, and Metastases
Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer.
PubMed 2012cited by 35position: first
Oncogenic MST1R activity in pancreatic and gastric cancer represents a valid target of HSP90 inhibitors.
PubMed 2012cited by 11position: first
Abstract 3211: Inhibition of Hsp90 impairs expression of VDAC in plasma and mitochondrial membrane influencing cancer cell metabolism
Abstract 4373: Targeting FGFR system in a model of HCC
Abstract 1916: Blockade of the fibroblast growth factor receptor (FGFR) system by the novel FGFR inhibitor BGJ398 modulates oncogenic signaling in human gastric cancer cells, endothelial cells and pericytes
Experimentelle Blockade von FGFR im HCC Modell